DNA X, Inc.: cash_and_equivalents
| Value | {"amount": 11298000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2019-12-31) |
| Status | current |
| Entity | DNA X, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/702d2ca4-2c00-4dd2-b236-3347a75659a3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-20-013676 · Open the official SEC filing →Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178697/cash-and-equivalents/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/702d2ca4-2c00-4dd2-b236-3347a75659a3
History
- no predecessors — first report